Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinagolide vs bromocriptine for psychological symptoms in hyperprolactinaemia
2010-021403-24Phase 4Terminated
- Sponsor
- Northern Lincolnshire and Goole NHS Foundation Trust
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of quinagolide in hyperprolactinemia (2 arms), sponsored by Northern Lincolnshire and Goole NHS Foundation Trust. Primary endpoint: Primary psychological endpoint. Started Oct 2010; status: terminated.
02
Drugs
quinagolide
03
Conditions
hyperprolactinemia
Beyond the preview
Go deeper on 2010-021403-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021403-24.